In 2021 the team behind Women’s Health Innovation Summit is organizing a series of events leading up to its signature event in the fall. The second event in this series, the Women 40+ Innovation Summit will take place virtually on June 22 & 23. Whilst there has been an improved focus on Women’s Health and Femtech Innovations, the industry has yet to extend its innovative arm…
1 in 8 families now struggle with infertility. Studies show that the average healthy couple has a 20 percent natural fertility rate per cycle, and miscarriages in women are increasing by about 1 percent each year. Additionally, Black and Latinx women are less likely to access fertility care and have a successful IVF pregnancy. As fertility continues to be in crisis, new artificial…
Innovate UK, the UK’s innovation agency, has awarded a Smart Grant to deep tech startup electronRx to support the development of their novel period pain relief technology, Ohmm. The discreet wearable device administers their proprietary neuromuscular electrical stimulation to neutralize the two main causes of menstrual pain, uterine cramps and inflammation, providing drug-free, long-lasting relief. electronRx CEO and Founder, Dr. Bipin Patel,…
U.S. based femtech startup LiquidGoldConcept announced it has been awarded an additional $55,000 in National Institutes of Health (NIH) funding in support of its Lactation Simulation Models (LSM) and Newborn Oral Assessment and Latch Simulators (NORALSim). The new grant is in addition to $250,000 in NIH support the company received in July of 2020 for its breastfeeding training technology. The $55,000 grant is through the National Centers for Clinical and Translational Science (NCATS), a…
ObsEva, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the appointment of Clive Bertram as Chief Commercial Officer and member of ObsEva’s Executive Committee, effective May 10, 2021. Wim Souverijns has served as Chief Commercial Officer of ObsEva since November 2018 and will leave the Company on June 30, 2021 to pursue a new opportunity.…
Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your…
“Your vagina is queen. Imvexxy is her ally. Long may she reign.” Imvexxy by TherapeuticsMD is the only bio-identical estrogen softgel insert available today. It was first approved in May 2018, when the drug launched with a small campaign. Last week, however, Imvexxy, made a comeback with a bold, new campaign: “Reign”. The new video ad is period-drama (think Bridgerton) inspired and…
Last week saw the launch of Female Founded, Female Led (or short FFFL), a new campaign to encourage consumers to shop at businesses that are owned and operated by women. The initiative was started by Dr. Sophia Yen, Founder and CEO of birth control startup Pandia Health, to address the issue of companies with white male founders swapping in women and POC…
